SG11201510733YA - Rocuronium preparation causing less pain, method for producing the same, and method for reducing and/or alleviating vascular pain to be induced using the same - Google Patents
Rocuronium preparation causing less pain, method for producing the same, and method for reducing and/or alleviating vascular pain to be induced using the sameInfo
- Publication number
- SG11201510733YA SG11201510733YA SG11201510733YA SG11201510733YA SG11201510733YA SG 11201510733Y A SG11201510733Y A SG 11201510733YA SG 11201510733Y A SG11201510733Y A SG 11201510733YA SG 11201510733Y A SG11201510733Y A SG 11201510733YA SG 11201510733Y A SG11201510733Y A SG 11201510733YA
- Authority
- SG
- Singapore
- Prior art keywords
- same
- pain
- induced
- producing
- reducing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2013138218 | 2013-07-01 | ||
| PCT/JP2014/066504 WO2015001995A1 (en) | 2013-07-01 | 2014-06-23 | Rocuronium preparation with improved vascular pain, method for producing same, and method for suppressing and relieving vascular pain using same |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201510733YA true SG11201510733YA (en) | 2016-01-28 |
Family
ID=52143574
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201510733YA SG11201510733YA (en) | 2013-07-01 | 2014-06-23 | Rocuronium preparation causing less pain, method for producing the same, and method for reducing and/or alleviating vascular pain to be induced using the same |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US10821119B2 (en) |
| EP (1) | EP3017817B1 (en) |
| JP (1) | JP5781698B2 (en) |
| KR (2) | KR102060160B1 (en) |
| CN (2) | CN110251459A (en) |
| AU (1) | AU2014285324B2 (en) |
| BR (1) | BR112015030877B1 (en) |
| CA (1) | CA2914154C (en) |
| DK (1) | DK3017817T3 (en) |
| ES (1) | ES2794529T3 (en) |
| HK (1) | HK1224183A1 (en) |
| IL (1) | IL243363B (en) |
| MX (1) | MX366310B (en) |
| NZ (1) | NZ714485A (en) |
| PH (1) | PH12015502850B1 (en) |
| PT (1) | PT3017817T (en) |
| RU (1) | RU2680405C2 (en) |
| SA (1) | SA515370275B1 (en) |
| SG (1) | SG11201510733YA (en) |
| WO (1) | WO2015001995A1 (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2015198456A1 (en) * | 2014-06-26 | 2015-12-30 | 丸石製薬株式会社 | Rocuronium formulation with improved stability |
| CN111374942B (en) * | 2018-12-30 | 2022-09-13 | 鲁南制药集团股份有限公司 | Steroid muscle relaxant injection and preparation method thereof |
| US20230014293A1 (en) | 2021-07-02 | 2023-01-19 | Fresenius Kabi Austria Gmbh | Aqueous, room-temperature stable rocuronium composition |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8708886D0 (en) | 1987-04-14 | 1987-05-20 | Akzo Nv | 2beta-morpholino-androstane derivatives |
| US5418226A (en) * | 1992-04-22 | 1995-05-23 | Akzo N.V. | Monoquaternary 2,16-bispiperidinylandrostane derivatives |
| JP2925054B2 (en) | 1993-08-20 | 1999-07-26 | 宇部興産株式会社 | Method for making hydrophobic substance hydrophilic |
| US6030941A (en) * | 1996-05-01 | 2000-02-29 | Avi Biopharma, Inc. | Polymer composition for delivering substances in living organisms |
| AU1874499A (en) * | 1997-11-27 | 1999-06-16 | Akzo Nobel N.V. | A pharmaceutical formulation of monoquaternary 2,16-bispiperidinylandrostane forintramuscular administration |
| US6911455B2 (en) * | 1999-12-22 | 2005-06-28 | Smithkline Beecham Corporation | Methods for preparing pharmaceutical formulations |
| EP1951248A4 (en) | 2005-11-14 | 2011-05-25 | Peter D Winch | Novel colored solutions of injectable drugs and their pharmaceutically acceptable salts |
| CN101400369A (en) * | 2005-11-14 | 2009-04-01 | P·D·温施 | Novel colored solutions of injectable drugs and their pharmaceutically acceptable salts |
| JP5157454B2 (en) | 2005-12-29 | 2013-03-06 | ニプロ株式会社 | Aqueous pharmaceutical preparations containing platinum complexes |
| RU2329799C1 (en) | 2006-11-13 | 2008-07-27 | Федеральное государственное учреждение Третий Центральный Военный Клинический госпиталь имени А.А. Вишневского Министерства обороны РФ | Anaesthesia method applied for adrenalectomy caused by epinephros pheochromocytoma |
| WO2008065142A1 (en) | 2006-11-29 | 2008-06-05 | N.V. Organon | Stabilized solution of rocuronium comprising a sulfoalkyl-ether-beta-cyclodextrin derivative |
| AU2011337781B2 (en) | 2010-11-29 | 2016-03-17 | Otsuka Pharmaceutical Factory, Inc. | Infusion preparation |
-
2014
- 2014-06-23 MX MX2015017549A patent/MX366310B/en active IP Right Grant
- 2014-06-23 RU RU2016102844A patent/RU2680405C2/en active
- 2014-06-23 CN CN201910588071.0A patent/CN110251459A/en active Pending
- 2014-06-23 SG SG11201510733YA patent/SG11201510733YA/en unknown
- 2014-06-23 JP JP2014530435A patent/JP5781698B2/en active Active
- 2014-06-23 BR BR112015030877-5A patent/BR112015030877B1/en active IP Right Grant
- 2014-06-23 KR KR1020177015581A patent/KR102060160B1/en active IP Right Grant
- 2014-06-23 CN CN201480037714.8A patent/CN105431151A/en active Pending
- 2014-06-23 EP EP14820424.1A patent/EP3017817B1/en active Active
- 2014-06-23 NZ NZ714485A patent/NZ714485A/en unknown
- 2014-06-23 PT PT148204241T patent/PT3017817T/en unknown
- 2014-06-23 AU AU2014285324A patent/AU2014285324B2/en active Active
- 2014-06-23 US US14/898,259 patent/US10821119B2/en active Active
- 2014-06-23 KR KR1020167002704A patent/KR101803857B1/en active IP Right Grant
- 2014-06-23 ES ES14820424T patent/ES2794529T3/en active Active
- 2014-06-23 WO PCT/JP2014/066504 patent/WO2015001995A1/en active Application Filing
- 2014-06-23 CA CA2914154A patent/CA2914154C/en active Active
- 2014-06-23 DK DK14820424.1T patent/DK3017817T3/en active
-
2015
- 2015-12-14 SA SA515370275A patent/SA515370275B1/en unknown
- 2015-12-22 PH PH12015502850A patent/PH12015502850B1/en unknown
- 2015-12-27 IL IL243363A patent/IL243363B/en active IP Right Grant
-
2016
- 2016-10-27 HK HK16112421.6A patent/HK1224183A1/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUE060672T2 (en) | Microorganisms and methods for producing sialylated and n-acetylglucosamine-containing oligosaccharides | |
| EP2953012A4 (en) | Electronic skin, preparation method and use thereof | |
| EP2836270A4 (en) | Systems and methods related to the treatment of back pain | |
| EP3058938A4 (en) | Plant composition having moisturizing, anti-wrinkle, and anti-allergic efficacies, and preparation method thereof | |
| HK1225752A1 (en) | Softening compositions including fermented fruit solutions and methods for making and using the same | |
| HK1209671A1 (en) | Aesthetic treatment device and method | |
| SG10201707565WA (en) | Oligosaccharide compositions, glycoproteins and methods to produce the same in prokaryotes | |
| EP3050437A4 (en) | Glucan beverage and preparation method therefor | |
| PT3021881T (en) | Cross-linked hyaluronic acid, process for the preparation thereof and use thereof in the aesthetic field | |
| EP3052078A4 (en) | Methods and compositions for improving the appearance of skin | |
| HK1219229A1 (en) | Compositions and methods for pain relief without numbness | |
| HRP20182199T1 (en) | Solid preparations comprising tofogliflozin and method for producing the same | |
| EP3066936A4 (en) | Thickening composition and method for producing same | |
| EP2967406A4 (en) | Method and system to calculate qeeg | |
| EP3027049A4 (en) | Treatment of beverages to reduce the effects of noxious constituents | |
| IL245296A0 (en) | Herbal composition, process for its preparation and use thereof | |
| IL243363B (en) | Rocuronium preparation causing less pain, method for producing the same ,and method for reducing and/or alleviating vascular pain to be induced using the same | |
| EP3079685A4 (en) | Sulfamate derivative compounds for use in treating or alleviating pain | |
| EP2960225A4 (en) | New 3,3',5,5'-tetraisopropyl-4,4'-diphenol crystal form and preparation method thereof | |
| EP3079687A4 (en) | Sulfamate derivative compounds for use in treating or alleviating pain | |
| EP3080246A4 (en) | Compositions and methods for producing and administering brown adipocytes | |
| EP3049123A4 (en) | Catheter locking formulation and method to prepare same | |
| HK1197037A1 (en) | Composition to be applied to the skin, and use thereof | |
| GB2521356B (en) | Antibodies for use in treating conditions related to specific PCKS9 variants and associated diagnostic methods | |
| IL229925A0 (en) | Composition for the treatment of alopecia and method for producing thereof |